CVS Health Corp. buy Barclays PLC
Summary
This prediction ended on 11.10.25 with a price of €67.97. The prediction had a final performance of 10.54%. Barclays_PLC has a follow-up prediction for CVS Health Corp. where he still thinks CVS Health Corp. is a Buy. A total of €1.25 was paid as dividends for this prediction. Barclays_PLC has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CVS Health Corp. | 2.318% | 2.318% | 36.691% |
| iShares Core DAX® | -1.933% | 2.239% | 16.921% |
| iShares Nasdaq 100 | -0.972% | 0.226% | 5.003% |
| iShares Nikkei 225® | -2.056% | 5.685% | 19.218% |
| iShares S&P 500 | -1.185% | 0.867% | 2.378% |
Comments by Barclays_PLC for this prediction
In the thread CVS Health Corp. diskutieren
In the thread Trading CVS Health Corp.